Accessibility Menu
 
Precision BioSciences logo

Precision BioSciences

(NASDAQ) DTIL

Current Price$7.16
Market Cap$184.49M
Since IPO (2019)-99%
5 Year-97%
1 Year+27%
1 Month+30%

Precision BioSciences Financials at a Glance

Market Cap

$184.49M

Revenue (TTM)

$34.26M

Net Income (TTM)

$46.61M

EPS (TTM)

$-5.18

P/E Ratio

-1.38

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$7.16

Volume

227,212

Open

$6.91

Previous Close

$7.15

Daily Range

$6.77 - $7.25

52-Week Range

$3.53 - $8.82

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precision BioSciences

Industry

Biotechnology

Employees

68

CEO

Michael Amoroso, EMBA

Headquarters

Durham, NC 27701, US

DTIL Financials

Key Financial Metrics (TTM)

Gross Margin

94%

Operating Margin

-2%

Net Income Margin

-1%

Return on Equity

-63%

Return on Capital

-36%

Return on Assets

-30%

Earnings Yield

-72.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$184.49M

Shares Outstanding

25.80M

Volume

227.21K

Avg. Volume

268.73K

Financials (TTM)

Gross Profit

$31.51M

Operating Income

$52.15M

EBITDA

$49.40M

Operating Cash Flow

$65.84M

Capital Expenditure

$85.00K

Free Cash Flow

$65.93M

Cash & ST Invst.

$115.58M

Total Debt

$28.81M

Precision BioSciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$34.20M

+5261.1%

Gross Profit

$33.53M

+5154.9%

Gross Margin

98.02%

N/A

Market Cap

$184.49M

N/A

Market Cap/Employee

$1.71M

N/A

Employees

108

N/A

Net Income

$19.25M

+208.5%

EBITDA

$13.19M

+179.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$86.78M

+54.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$27.30M

-5.0%

Short Term Debt

$1.51M

+14.2%

Return on Assets

-30.18%

N/A

Return on Invested Capital

-35.84%

N/A

Free Cash Flow

$11.28M

+39.9%

Operating Cash Flow

$11.25M

+39.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNTBConnect Biopharma Holdings Limited
$2.47-2.37%
ARTVArtiva Biotherapeutics, Inc.
$10.24+17.43%
ALXOALX Oncology Holdings Inc.
$1.70+7.59%
ATYRaTyr Pharma, Inc.
$0.81+5.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$16.10+0.04%
AAPLApple
$271.35+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About DTIL

What is the current price of Precision BioSciences?

Precision BioSciences is trading at $7.15 per share.

What is the 52-week range for Precision BioSciences?

Over the past 52 weeks, Precision BioSciences has traded between $3.53 and $8.82.

How much debt does Precision BioSciences have?

As of the most recent reporting period, Precision BioSciences reported total debt of $28.81M.

How much cash does Precision BioSciences have on hand?

Precision BioSciences reported $110.82M in cash and cash equivalents in its most recent financial results.

What is Precision BioSciences’s dividend yield?

Precision BioSciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.